Immediate Impact
51 standout
Citing Papers
Type 2 chronic inflammatory diseases: targets, therapies and unmet needs
2023 Standout
Oral delivery of therapeutic peptides and proteins: Technology landscape of lipid-based nanocarriers
2022 Standout
Works of Maria Welsh being referenced
Phase I and Phase II Safety and Efficacy Trial of Intercellular Adhesion Molecule-1 Antisense Oligodeoxynucleotide (ISIS 2302) for the Prevention of Acute Allograft Rejection
2004
Demographic factors influencing cyclosporine pharmacokinetic parameters in patients with uremia: Racial differences in bioavailability
1992
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Maria Welsh | 621 | 299 | 367 | 18 | 861 | |
| Ian S Westley | 515 | 157 | 378 | 22 | 743 | |
| Linda Schoenberg | 536 | 355 | 203 | 11 | 790 | |
| Richard W. Carson | 366 | 174 | 201 | 14 | 838 | |
| Sheila Zuckerman | 724 | 258 | 426 | 11 | 946 | |
| Johannes M. M. Boots | 772 | 438 | 243 | 27 | 1.1k | |
| Eleanor Elstein | 388 | 297 | 169 | 24 | 898 | |
| K. Venkateswara Rao | 617 | 351 | 167 | 39 | 1.1k | |
| F. Villemain | 605 | 207 | 175 | 13 | 751 | |
| S. Barbier | 489 | 186 | 210 | 11 | 992 | |
| Ilse P. van der Heiden | 327 | 109 | 395 | 17 | 867 |
All Works
Loading papers...